Verastem Oncology
VSTM
#6555
Rank
NZ$1.45 B
Marketcap
NZ$11.57
Share price
-7.73%
Change (1 day)
-30.20%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -NZ$0.36 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$87.52 Million. In 2025 the company made an earning of -NZ$0.39 Billion a decrease over its 2024 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.36 Billion-8.59%
2025 -NZ$0.39 Billion60.57%
2024 -NZ$0.24 Billion49.31%
2023 -NZ$0.16 Billion18.36%
2022 -NZ$0.14 Billion3.67%
2021 -NZ$0.14 Billion5.43%
2020 -NZ$0.13 Billion-54.74%
2019 -NZ$0.28 Billion105.99%
2018 -NZ$0.14 Billion6.83%
2017 -NZ$0.13 Billion86.06%
2016 -NZ$66.62 Million-37.03%
2015 -NZ$0.11 Billion8.43%
2014 -NZ$97.56 Million29.52%
2013 -NZ$75.32 Million28.6%
2012 -NZ$58.57 Million133.9%
2011 -NZ$25.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.73 B-3,551.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.65 B-820.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.07 B-3,643.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-NZ$15.45 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA